A

argenx

Develops antibody-based therapies for autoimmune diseases

Digital Technology Business Lead - Research

IT OperationsConfirmed live in the last 24 hours
Full-timeGhent, Belgium

About the Job

Requirements

  • Broad knowledge of end-to-end scientific processes in a biopharmaceutical research and development lifecycle, including early Discovery (target identification, lead identification and selection), Pre-Clinical Development (CMC, toxicology), and Translational Science (biomarkers, early clinical data).
  • Broad understanding of digital technologies, platforms, and data management practices that enable and accelerate pharmaceutical research.
  • Skilled in developing and executing cohesive, multi-year technology roadmaps that drive innovation across a diverse scientific landscape.
  • Ability to translate complex scientific strategies from multiple domains into a single, actionable, outcomes-driven technology portfolio.
  • Expert knowledge of scientific data management principles, research informatics platforms, and GxP data integrity requirements (GLP, GCP) in a regulated scientific environment.
  • Ability to work collaboratively and effectively within cross-functional teams and networks.
  • Agility, adaptability, comfort with ambiguity, trust-building, and resilience.
  • Ability to operate in a dynamic, complex, fast-moving, and frequently changing business environment.
  • Demonstrable experience with project management, proactive planning, complex priority setting, and securing alignment.
  • Advanced degree in Life Sciences, Bioinformatics, or a related field.
  • Experience in a senior IT business partnership or technology strategy role with broad exposure across the research and development lifecycle (Discovery, Pre-Clinical, Translational); 6+ years of experience.
  • Experience owning and delivering a large, complex portfolio of technology initiatives and digital roadmaps that have successfully driven scientific innovation.
  • Experience managing relationships with a diverse set of senior stakeholders within a dynamic and fast-paced research and development organization.
  • Occasional international travel is required.

Responsibilities

  • Define priorities and manage the direction of the strategic technology partnership with leadership across the entire Research organization, including Discovery, Pre-Clinical, and Translational Science.
  • Develop, own, and champion a unified, multi-year digital technology roadmap for Research, applying an innovative mindset to accelerate the scientific lifecycle.
  • Govern the consolidated portfolio of technology initiatives for all of Research, from shaping and prioritizing new ideas through ensuring value realization.
  • Provide outcome-driven leadership, fostering an environment where individuals are empowered to take ownership and initiative.
  • Act as a senior technology advisor, translating complex and diverse scientific needs across the research pipeline into a clear, integrated technology execution plan.
  • Ensure technology solutions are built with high quality and adhere to appropriate industry standards for data integrity, security, and scientific validation, including GLP and GCP.
  • Foster relationships and open communication between scientific stakeholders, digital technology teams, and external partners to achieve shared goals.
  • Champion a growth mindset within the team and with partners, encouraging continuous learning from successes and failures to drive continuous improvement.
  • Manage complex escalations and interdependencies across the research domain, demonstrating resilience and agility to keep high-impact initiatives moving forward.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs